drugset / Trial / NCT01691261

A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

NCT01691261 ↗

NaSingle-groupOpen-labelTreatment

Summary

Phase 1 trial of retinal pigment epithelium replacement in subjects with wet age-related macular degeneration in whom there is rapidly progressing vision loss

Timeline

Start
2021-10-14
Primary completion
2023-10-10
Completion
2024-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05206388 Cell therapy — Other